These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9183140)

  • 1. Neuroleptic-related dyskinesias in autistic children: a prospective, longitudinal study.
    Campbell M; Armenteros JL; Malone RP; Adams PB; Eisenberg ZW; Overall JE
    J Am Acad Child Adolesc Psychiatry; 1997 Jun; 36(6):835-43. PubMed ID: 9183140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haloperidol-related dyskinesias and pre- and perinatal complications in autistic children.
    Armenteros JL; Adams PB; Campbell M; Eisenberg ZW
    Psychopharmacol Bull; 1995; 31(2):363-9. PubMed ID: 7491393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeated episodes of neuroleptic-related dyskinesias in autistic children.
    Malone RP; Ernst M; Godfrey KA; Locascio JJ; Campbell M
    Psychopharmacol Bull; 1991; 27(2):113-7. PubMed ID: 1681562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of stereotypies from neuroleptic-related dyskinesias in autistic children.
    Meiselas KD; Spencer EK; Oberfield R; Peselow ED; Angrist B; Campbell M
    J Clin Psychopharmacol; 1989 Jun; 9(3):207-9. PubMed ID: 2500463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors related to haloperidol response and dyskinesias in autistic children.
    Locascio JJ; Malone RP; Small AM; Kafantaris V; Ernst M; Lynch NS; Overall JE; Campbell M
    Psychopharmacol Bull; 1991; 27(2):119-26. PubMed ID: 1924657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term efficacy of haloperidol in autistic children: continuous versus discontinuous drug administration.
    Perry R; Campbell M; Adams P; Lynch N; Spencer EK; Curren EL; Overall JE
    J Am Acad Child Adolesc Psychiatry; 1989 Jan; 28(1):87-92. PubMed ID: 2914841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroleptic-related dyskinesias in autistic children: a prospective study.
    Perry R; Campbell M; Green WH; Small AM; Die Trill ML; Meiselas K; Golden RR; Deutsch SI
    Psychopharmacol Bull; 1985; 21(1):140-3. PubMed ID: 3885290
    [No Abstract]   [Full Text] [Related]  

  • 8. Haloperidol withdrawal and weight changes in autistic children.
    Silva RR; Malone RP; Anderson LT; Shay J; Campbell M
    Psychopharmacol Bull; 1993; 29(2):287-91. PubMed ID: 8290679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case series: spectrum of neuroleptic-induced movement disorders and extrapyramidal side effects in childhood-onset schizophrenia.
    Kumra S; Jacobsen LK; Lenane M; Smith A; Lee P; Malanga CJ; Karp BI; Hamburger S; Rapoport JL
    J Am Acad Child Adolesc Psychiatry; 1998 Feb; 37(2):221-7. PubMed ID: 9473920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risperidone treatment in children and adolescents with autism: short- and long-term safety and effectiveness.
    Malone RP; Maislin G; Choudhury MS; Gifford C; Delaney MA
    J Am Acad Child Adolesc Psychiatry; 2002 Feb; 41(2):140-7. PubMed ID: 11837403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyproheptadine in the treatment of autistic disorder: a double-blind placebo-controlled trial.
    Akhondzadeh S; Erfani S; Mohammadi MR; Tehrani-Doost M; Amini H; Gudarzi SS; Yasamy MT
    J Clin Pharm Ther; 2004 Apr; 29(2):145-50. PubMed ID: 15068403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroleptic-related dyskinesias and stereotypies in autistic children: videotaped ratings.
    Shay J; Sanchez LE; Cueva JE; Armenteros JL; Overall JE; Campbell M
    Psychopharmacol Bull; 1993; 29(3):359-63. PubMed ID: 7907183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risperidone: new indication. Behavioural disorders in children with autism or mental disabilities: no progress.
    Prescrire Int; 2006 Apr; 15(82):43-5. PubMed ID: 16602211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High incidence of tardive dyskinesia in older outpatients on low doses of neuroleptics.
    Harris MJ; Panton D; Caligiuri MP; Krull AJ; Tran-Johnson TK; Jeste DV
    Psychopharmacol Bull; 1992; 28(1):87-92. PubMed ID: 1609047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotypies and tardive dyskinesia: abnormal movements in autistic children.
    Campbell M; Locascio JJ; Choroco MC; Spencer EK; Malone RP; Kafantaris V; Overall JE
    Psychopharmacol Bull; 1990; 26(2):260-6. PubMed ID: 2236468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clozapine in tardive dyskinesia: observations from human and animal model studies.
    Tamminga CA; Thaker GK; Moran M; Kakigi T; Gao XM
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():102-6. PubMed ID: 7961550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tourette-like symptoms associated with neuroleptic therapy in an autistic child.
    Perry R; Nobler MS; Campbell M
    J Am Acad Child Adolesc Psychiatry; 1989 Jan; 28(1):93-6. PubMed ID: 2914842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum concentrations of haloperidol pyridinium metabolites and the relationship with tardive dyskinesia and parkinsonism: a cross-section study in psychiatric patients.
    Ulrich S; Sandmann U; Genz A
    Pharmacopsychiatry; 2005 Jul; 38(4):171-7. PubMed ID: 16025420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Utility of quetiapine in tardive dyskinesia].
    Navarro Pacheco BV; Montejo González AL; Martín Carrasco M
    Actas Esp Psiquiatr; 2003; 31(6):347-52. PubMed ID: 14639511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An open trial of risperidone in young autistic children.
    Nicolson R; Awad G; Sloman L
    J Am Acad Child Adolesc Psychiatry; 1998 Apr; 37(4):372-6. PubMed ID: 9549957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.